https://orcid.org/0000-0001-5120-8029
References
- DiMasi J, Grabowski H, Hansen R. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33.
- Gagnon M-A, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5(1):e1.
- Institute for Health & Socio-Economic Policy. The R&D smokescreen: the prioritization of marketing & sales in the pharmaceutical industry: IHSP. 2016. http://nurses.3cdn.net/e74ab9a3e937fe5646_afm6bh0u9.pdf. Accessed 12 Nov 2017
- Canadian pharmaceutical industry review 2013. IMS Brogan, Montreal. 2014. http://imsbrogancapabilities.com/YIR_2013_FINAL. Accessed 12 Nov 2017.
- Canadian pharmaceutical industry review 2014. IMS Brogan, Montreal. 2015. http://imsbrogancapabilities.com/YIR_2014_FINAL. Accessed 12 Nov 2017.
- Canadian pharmaceutical industry review 2015. IMS Brogan, Montreal. 2016. http://imsbrogancapabilities.com/YIR_2015_FINAL. Accessed 12 Nov 2017.
- Canadian pharmaceutical industry review 2016. QuintilesIMS, Montreal. 2017 http://imsbrogancapabilities.com/YIR_2016_FINAL. Accessed 12 Nov 2017.
- Patented Medicine Prices Review Board: Annual report 2013. PMPRB, Ottawa. 2014.
- Patented Medicine Prices Review Board: Annual report 2014. PMPRB, Ottawa. 2015.
- Patented Medicine Prices Review Board: Annual report 2015. PMPRB, Ottawa. 2016.
- Patented Medicine Prices Review Board: Annual report 2016. PMPRB, Ottawa. 2017.
- IMC. Research and development. Innovative medicines Canada, Ottawa. 2017 http://innovativemedicines.ca/innovation/research-and-development/. Accessed 12 Nov 2017.
- Hwang T, Carpenter D, Lauffenburger J, Wang B, Franklin J, Kesselheim A. Failure of investigational drugs in late-stage clinical development and publication of trial results. JAMA Intern Med. 2016;176:1826–33.
- Rx&D. Where we stand: detailing. Ottawa, Canada’s research-based pharmaceutical companies. 2010.
- Lexchin J. The relationship between promotional spending on drugs and their therapeutic gain: a cohort analysis. CMAJ Open. 2017;5:E724–8.
- Mintzes B, Lexchin J, Sutherland J, Beaulieu M-D, Wilkes M, Durrieu G, Reynolds E. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med. 2013;28:1368–75.
- Ernst & Young LLP. Innovative medicines Canada data analytics and members’ economic footprint and impact in Canada. Vancouver: EY; 2017.